Production (Stage)
Solid Biosciences Inc.
SLDB
$2.81
-$0.08-2.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.77% | -29.87% | -12.78% | -0.48% | 0.52% |
| Total Depreciation and Amortization | 13.63% | -4.88% | -25.01% | -14.29% | -6.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 216.95% | 146.75% | 208.51% | 167.58% | 165.44% |
| Change in Net Operating Assets | 163.20% | 124.68% | 73.65% | 67.42% | -1,226.77% |
| Cash from Operations | -16.74% | -6.19% | 15.44% | 22.64% | 7.50% |
| Capital Expenditure | 45.51% | 56.83% | 76.33% | 66.82% | 65.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.17% | -237.78% | -804.80% | -154.36% | -317.15% |
| Cash from Investing | 92.34% | -266.02% | -130.69% | -132.85% | -212.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -422.73% | -240.91% | -- |
| Issuance of Common Stock | 78.70% | 4,000.61% | 61.35% | 56.86% | 58.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.66% | -- | -- | -- | -- |
| Cash from Financing | 85.68% | 3,821.75% | 49.96% | 45.76% | 47.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 297.97% | 107.79% | 154,450.00% | -88.22% | -235.66% |